Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Deliv ; 30(1): 2158964, 2023 Dec.
Article in English | MEDLINE | ID: mdl-36587631

ABSTRACT

The purpose of this study was to develop poloxamer (P407)-based in-situ thermogellable hydrogels with reducing concentration of P407 by adding hypromellose (HPMC) and with enhancing mucoadhesion of resulting hydrogels by adding hyaluronic acid (HA) for prolonging ocular delivery of hydroxypropyl-ß-cyclodextrin (HPßCD)-solubilized testosterone (TES). Results demonstrated that 0.5% TES solution was successfully solubilized with adding 10% HPßCD. Non-gellable 13% P407 sol became in-situ gellable with adding 2.0-2.5% HPMC and mucoadhesibility was further imporved with adding 0.3% HA-L (low MW) or HA-H (high MW). Optimized 0.5% HPßCD-solubilized TES P407-based thermogellable hydrogels with enhancement of mucoadhesion for prolonging ocular delivery comprised 13% P407, 2.5% HPMC, and 0.3% HA-L or HA-H. Furthermore, rheological measurements under simulated eye blinking confirmed that non-thixotropic properties of optimized hydrogels could be spreaded evenly and retain a greater amount of drug-loaded hydrogels on the ocular surface for a longer period to prolong drug delivery. Compared with conventional eye drops, the prolonged residence time of optimized hydrogels from ex vivo and in vivo studies were observed, indicating relationships between rheological properties and in vivo performances. It was concluded that P407-based thermosensitive hydrogels with reducing concentration of P407 and enhancing mucoadhesion was successfully formulated by adding 2.5% HPMC and 0.3% HA in 13% P407 for potentially accomplishing effective clinical treatment of DED.


Subject(s)
Hyaluronic Acid , Poloxamer , Hypromellose Derivatives , 2-Hydroxypropyl-beta-cyclodextrin , Temperature , Hydrogels
2.
Phys Rev Lett ; 121(19): 196801, 2018 Nov 09.
Article in English | MEDLINE | ID: mdl-30468588

ABSTRACT

We propose a tune-free scheme to realize Kramers pairs of Majorana bound states in recently discovered higher-order topological insulators (HOTIs). We show that, by bringing two hinges of a HOTI into the proximity of an s-wave superconductor, the competition between local and crossed Andreev pairing leads to the formation of Majorana Kramers pairs, when the latter pairing dominates over the former. We demonstrate that such a topological superconductivity is stabilized by moderate electron-electron interactions. The proposed setup avoids the application of a magnetic field or local voltage gates, and requires weaker interactions compared with nonhelical nanowires.

3.
Biomaterials ; 106: 111-8, 2016 11.
Article in English | MEDLINE | ID: mdl-27552321

ABSTRACT

The ongoing battle against current and rising viral infectious threats has prompted increasing effort in the development of vaccine technology. A major thrust in vaccine research focuses on developing formulations with virus-like features towards enhancing antigen presentation and immune processing. Herein, a facile approach to formulate synthetic virus-like particles (sVLPs) is demonstrated by exploiting the phenomenon of protein corona formation induced by the high-energy surfaces of synthetic nanoparticles. Using an avian coronavirus spike protein as a model antigen, sVLPs were prepared by incubating 100 nm gold nanoparticles in a solution containing an optimized concentration of viral proteins. Following removal of free proteins, antigen-laden particles were recovered and showed morphological semblance to natural viral particles under nanoparticle tracking analysis and transmission electron microscopy. As compared to inoculation with free proteins, vaccination with the sVLPs showed enhanced lymphatic antigen delivery, stronger antibody titers, increased splenic T-cell response, and reduced infection-associated symptoms in an avian model of coronavirus infection. Comparison to a commercial whole inactivated virus vaccine also showed evidence of superior antiviral protection by the sVLPs. The study demonstrates a simple yet robust method in bridging viral antigens with synthetic nanoparticles for improved vaccine application; it has practical implications in the management of human viral infections as well as in animal agriculture.


Subject(s)
Coronavirus Infections/immunology , Coronavirus Infections/prevention & control , Nanoparticles/administration & dosage , Protein Corona/chemistry , Spike Glycoprotein, Coronavirus/chemistry , Vaccines, Virus-Like Particle/administration & dosage , Vaccines, Virus-Like Particle/immunology , Animals , Birds , Gold/administration & dosage , Gold/chemistry , Nanoparticles/chemistry , Protein Engineering/methods , Treatment Outcome , Vaccines, Virus-Like Particle/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...